Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients

Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients

Background: The aim of the present survey was to investigate the changes associated with fexofenadine administration in the quality of life (QOL) of Japanese cedar pollinosis patients. Methods: After obtaining informed consent, volunteers suffering from Japanese cedar pollinosis were divided into tw...

Full description

Bibliographic Details
Main Authors:	Kimihiro Okubo, Minoru Gotoh, Kenichi Shimada, Masayo Ritsu, Makoto Kobayashi, Minoru Okuda
Format:	Article
Language:	English
Published:	Elsevier 2004-01-01
Series:	Allergology International
Subjects:	allergic rhinitis cedar pollinosis daily life fexofenadine quality of life
Online Access:	http://www.sciencedirect.com/science/article/pii/S1323893015311242

Similar Items

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Minoru Gotoh, et al.
Published: (2005-01-01)

Delay of Onset of Symptoms of Japanese Cedar Pollinosis by Treatment with a Leukotriene Receptor Antagonist
by: Minoru Gotoh, et al.
Published: (2011-01-01)

Inhibition of the Antigen Provoked Nasal Reaction by Second-generation Antihistamines in Patients with Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2006-01-01)

Association of Japanese cedar pollinosis and sensitization with HLA-DPB1 in the Japanese adolescent
by: Wataru Morii, et al.
Published: (2018-01-01)

Cedar Pollinosis and Mortality: A Population-Based Prospective Cohort Study in Japan
by: Kenichi Mori, et al.
Published: (2019-02-01)

The Relationship between Pollen Count Levels and Prevalence of Japanese Cedar Pollinosis in Northeast Japan
by: Kohei Honda, et al.
Published: (2013-01-01)

Clinical aspects of Japanese cedar pollinosis
by: Minoru Okuda, et al.
Published: (1998-01-01)

An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients
by: Imanaka, Takahiro
Published: (2019)

A Randomized Double-Blind Comparative Study of Sublingual Immunotherapy for Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2009-01-01)

The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status
by: Masayuki Hojo, et al.
Published: (2015-04-01)

Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis
by: Takashi Fujimura, et al.
Published: (2018-12-01)

Effect of Cry-consensus Peptide, a Novel Recombinant Peptide for Immunotherapy of Japanese Cedar Pollinosis, on an Experimental Allergic Rhinitis Model in B10.S Mice
by: Masako Tsunematsu, et al.
Published: (2007-01-01)

Effects of antihistamine on up-regulation of histamine H1 receptor mRNA in the nasal mucosa of patients with pollinosis induced by controlled cedar pollen challenge in an environmental exposure unit
by: Yoshiaki Kitamura, et al.
Published: (2015-11-01)

Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy
by: Kuninori Otsuka, et al.
Published: (2020-09-01)

Allergen‐specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season
by: Kuninori Otsuka, et al.
Published: (2020-09-01)

Present Situation of Cedar Pollinosis in Japan and its Immune Responses
by: Yoshitaka Okamoto, et al.
Published: (2009-01-01)

Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment
by: Toshihiro Osada, et al.
Published: (2021-07-01)

Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial
by: Yasuyuki Nomura, et al.
Published: (2021-01-01)

Biomarkers for Allergen Immunotherapy in Cedar Pollinosis
by: Takao Fujisawa, et al.
Published: (2009-01-01)

Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy
by: Takashi Fujimura, et al.
Published: (2015-10-01)

Measurement of Japanese Cedar Pollen-Specific IgE in Nasal Secretions
by: Hiroshi Sakaida, et al.
Published: (2014-01-01)

Medical Consultation Rate of Allergic Rhinitis and Pollinosis Surveillance in Aichi, Japan
by: YAMADA, SHIN'YA, et al.
Published: (1994)

Preventative Effect of a Flavonoid, Enzymatically Modified Isoquercitrin on Ocular Symptoms of Japanese Cedar Pollinosis
by: Toru Hirano, et al.
Published: (2009-01-01)

Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis
by: Qingliang Kong, et al.
Published: (2020-03-01)

Determining Minimal Clinically Important Differences in Japanese Cedar/Cypress Pollinosis Patients
by: Takaya Higaki, et al.
Published: (2013-01-01)

Effect of pollen exposure on serum IgE and IgG antibody responses in Japanese cedar pollinosis patients
by: Koichi Imaoka, et al.
Published: (1996-01-01)

Serum Concentrations of Antigen-Specific IgG4 in Patients with Japanese Cedar Pollinosis
by: Shiori Kitaya, et al.
Published: (2021-07-01)

Omalizumab is Effective and Safe in the Treatment of Japanese Cedar Pollen-induced Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2006-01-01)

Two Thirds of Forest Walkers with Japanese Cedar Pollinosis Visit Forests even During the Pollen Season
by: Emi Morita, et al.
Published: (2009-01-01)

'Benifuuki' Green Tea Containing O-Methylated Catechin Reduces Symptoms of Japanese Cedar Pollinosis: A Randomized, Double- Blind, Placebo-Controlled Trial
by: Sawako Masuda, et al.
Published: (2014-01-01)

Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis
by: Yasuyuki Noyama, et al.
Published: (2016-07-01)

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study
by: Kimihiro Okubo, et al.
Published: (2017-01-01)

The Differences in the Involvements of Loci of Promoter Region and Ile50Val in Interleukin-4 Receptor α Chain Gene between Atopic Dermatitis and Japanese Cedar Pollinosis
by: Takeshi Tanaka, et al.
Published: (2012-01-01)

Determining an Appropriate Time to Start Prophylactic Treatment with Intranasal Corticosteroids in Japanese Cedar Pollinosis
by: Takenori Haruna, et al.
Published: (2019-01-01)

Continuous 6-Year Follow-Up Study of Sensitization to Japanese Cedar Pollen and Onset in Schoolchildren
by: Atsuko Kanazawa, et al.
Published: (2014-01-01)

Allergic rhinitis from the perspective of an allergist
by: Olga I. Sidorovich, et al.
Published: (2019-03-01)

Effect of concurrent administration of nobiletin and β-lactoglobulin on the symptoms of Japanese cedar pollinosis models in mice
by: Sho Yasunaga, et al.
Published: (2016-04-01)

Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial
by: Seiichiro Makihara, et al.
Published: (2012-01-01)